From 'Meh' To Memorable: Tap Into What Doctors Really Think To Level Up Your Messaging Registration

Date:9/18/2025

Time:1:00 PM EDT

Duration:60 minutes

Pharma marketing leaders, are you ready to completely take the guesswork out of marketing message development? If your answer is YES, this webinar is for you. We’ll show you how AI-powered real-time insights can help you connect with the right doctors, craft personalized messaging and content, and gain valuable insights into competitors’ treatments – all to drive engagement and deliver real results.

We’re talking smarter strategies powered by behavioral intel and HCP sentiment that traditional datasets just can’t deliver. Plus, we’ll walk through real-world examples of how AI uncovers doctor-patient interactions to reveal treatment decisions that can elevate your marketing plans, strategies and tactics.

You’ll learn how to:

Unlock HCP treatment rationale — take real-world insights about treatment starts, stops, and switches — and turn that knowledge into personalized messaging and content that drives engagement and adoption.
Target smarter with behavioral intel to match the right physician segments with the right campaigns, NPP programs, and materials.
Elevate outreach and drive ROI by using AI insights to customize materials and gain competitor treatment insights.

If you're already registered for the "From 'Meh' To Memorable: Tap Into What Doctors Really Think To Level Up Your Messaging" webcast, click below:

ALREADY REGISTERED?

SpeakerS

Fleur Lee

Senior Director

Dayvigo, U.S. Brand Lead, Eisai Inc.

Fleur Lee is the new brand lead for Dayvigo at Eisai Inc., and most recently was the HCP launch lead for Leqembi, the first disease modifying agent to receive accelerated and full approval for the treatment of Alzheimer’s disease. Prior to Eisai, Fleur brought over 24 years of industry experience, with a diverse background across many therapeutic areas. She started her career at Pfizer, working on a range of award-winning and highly recognized brands. From there, Fleur joined the specialty biotech company Trius Therapeutics, where she led the U.S. commercial launch for Sivextro, an anti-MRSA agent. Fleur was also the North American market access lead for Praluent and the global business development market access lead for the CV franchise at Sanofi. Fleur holds a Master’s in Public Health from Columbia University and a BS in Sociology from the University of Illinois.

Susan Duffy

President, Comms

Amplity

As President of Amplity’s Comms Business Line, Susan leads creative communications professionals in delivering medical communications, media, and strategic marketing solutions to help patients get on and stay on the right therapies. Susan comes to Amplity with 25 + years of biopharma experience, most recently as an Executive Vice President at the BGB Group. Her marketing experience spans a variety of life science companies, channels, and therapeutic areas. Susan has supported brands in mature and competitive markets – as well as brands that have defined and established new categories and standards of care. Susan has her BA in English Literature from Fordham University.

Steve Ennen

Director, New Client Partnerships

Amplity

Steve has spent over 20 years helping organizations drive digital and data-driven transformation across industries. His journey started at the Wharton School, where he co-founded what’s now the Wharton AI and Analytics Program and taught MBA students while advising companies on advanced analytics. He’s launched businesses like SocialStrategy1, led transformation efforts at CENTRIS Marketing Science, and held senior roles at MJH Life Sciences and West Pharmaceutical Services. A sought-after speaker and thought leader, Steve has shared his expertise globally. At Amplity, Steve helps organizations leverage AnswerY, an AI-informed HCP insights platform, to solve challenges and optimize decision-making.